UNSPSC 51171653: Prucalopride succinate

This classification denotes a serotonin agonist with the molecular formula C18H26CLN3O3.C4H6O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4V2G75E1CK. European Medicines Agency schedules prucalopride succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB28850. The term prucalopride succinate is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule prucalopride succinate under HS 29349990 and SITC 51579.

As of Q4 2014, PRUCALOPRIDE SUCCINATE remains US FDA's Preferred Term for this commodity. SMILES: COCCCN1CCC(CC1)NC(=O)C2CC(C(C3C2OCC3)N)CL.C(CC(=O)O)C(=O)O.

UNSPSC 51171653 Prucalopride succinate is a Commodity code that does not reflect the work state and local governments are actually buying under this classification. The single recent opportunity tagged to the code—Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—concerns laboratory testing, staffing, and result reporting for criminal justice populations, not pharmaceutical procurement. The mismatch suggests the code was misapplied to the solicitation or that state and local contracting offices are not actively procuring prucalopride succinate as a line item under current UNSPSC taxonomy.

Collin County Community Supervision and Corrections Department posted RFP 2026-327 on September 25, 2026, with a due date of July 23, 2026 (note: the due date predates the posting date in the source, indicating a data error). The solicitation requests proposals for drug testing services at two sites in Plano and McKinney, with annual testing demand of approximately 25,031 tests across five-panel, six-panel, and ancillary testing methodologies. The estimated contract value is $600,000 over two years with three optional one-year renewal periods, and the anticipated award date is August 10, 2026. The county reserves the right to award in whole or in part to multiple vendors, with evaluation weighted 30 points for vendor understanding, 25 points for firm qualifications, 15 points for client references, and 30 points for cost. The code shows little relevant recent activity for pharmaceutical procurement.